Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001379647 | SCV001577483 | likely pathogenic | not provided | 2024-10-23 | criteria provided, single submitter | clinical testing | This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 118 of the NR2E3 protein (p.Val118Met). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This missense change has been observed in individuals with autosomal dominant retinitis pigmentosa (PMID: 19933183, 28981474). ClinVar contains an entry for this variant (Variation ID: 812353). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. |
Baylor Genetics | RCV003461304 | SCV004191581 | likely pathogenic | Enhanced S-cone syndrome | 2024-03-08 | criteria provided, single submitter | clinical testing | |
Sharon lab, |
RCV001003094 | SCV001161157 | likely pathogenic | Retinitis pigmentosa | 2019-06-23 | no assertion criteria provided | research |